• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    5.31 Down 0.19(3.45%) Apr 29, 4:00PM EDT
    |After Hours : 5.31 0.00 (0.00%) Apr 29, 4:55PM EDT
    Prev Close:5.50
    Open:5.45
    Bid:5.05 x 5000
    Ask:6.57 x 200
    1y Target Est:10.75
    Beta:2.40727
    Next Earnings Date: 5-May-16PGNX Earnings announcement
    Day's Range:5.25 - 5.53
    52wk Range:3.61 - 11.15
    Volume:738,332
    Avg Vol (3m):949,786
    Market Cap:371.41M
    P/E (ttm):N/A
    EPS (ttm):-0.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 3.45%371.41M
    NKTRDown 2.85%2.13B

    Key Statistics

    Forward P/E (1 yr):27.95
    P/S (ttm):127.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.21
    Quarterly EPS Est (Mar-16) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):0.18

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include Azedra, a radiotherapeutic product candidate, which is in Phase IIb clin... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback